NanoSphere Health Sciences (CSE:NSHS) President David Sutton was interviewed on #CanadaPotTalks, a Roundhouse Radio 98.3 radio show. The show is broadcast in collaboration with Niche Canada, a non-profit organization that supports the safe transition to cannabis legalization, and Steven Feldman, the owner of the social media account @CanadaPotStocks.
During the interview, Sutton discussed how NanoSphere entered the Canadian space by using the technology developed by Dr. Richard Kaufman to develop a nano-nutraceutical line of products. In designing these products, the company discovered the viability for this technology to be implemented in other spaces, including with cannabis, where the approach would be able to increase the drug’s bioavailability.
The company president also discussed the company’s primary product—the NanoSphere Delivery System—and described how it adapts the cannabinoid particles to make them easier to absorb and more effective. He also addressed the company’s other products, including a topical salve, which can assist in pain relief, anxiety reduction and sleep control. These products are becoming more available to patients as the company works to educate medical professionals of their benefits.
To listen to the full interview, click here. Interview begins near the 30 minute mark.
Click here to connect with NanoSphere Health Sciences (CSE:NSHS) for an investor presentation

Source: cirh2.streamon.fm


Achievements with Scalability and Compatibility Pave Way for Next Phase of Advancement

Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) is excited to announce that the Company’s holding, Arcology, a cluster-computing powered AI blockchain ecosystem with unlimited scalability, has updated its working roadmap in response to its Testnet 1.0 results

Keep reading... Show less

For the purposes of the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules, World High Life announces that the Company has 230,119,819 ordinary shares of 1p each in issue (“Ordinary Shares”), each share carrying the right to one vote. The figure of 230,119,819 should be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules

The Directors of the Company accept responsibility for the contents of this announcement.

Keep reading... Show less

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) announces that it has granted an aggregate of 400,000 options at an exercise price of CDN$1.00, exercisable for a period of five years, to directors and officers of the Company. The stock options are being granted pursuant to the terms of the Company’s stock option plan, and are subject to regulatory approval.

About TransCanna Holdings Inc.

Keep reading... Show less

Donation will benefit veteran-focused organizations and nonprofits, including all TruVet Program partners

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a United States -based leading medical cannabis company, announced today a donation for all TruVet Program partners year-to-date in honor of Veterans Day. A total of $15,000 representing a portion of the November proceeds from the Company’s limited-edition Freedom Pre-Roll product, will be shared among program partners, which are veteran-focused organizations andor nonprofits.

Keep reading... Show less

Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Aurora Cannibas, Inc. (“Aurora” or the “Company”) (NYSE:ACB) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Aurora securities between February 13, 2020, and September 4, 2020, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.comacb

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

Keep reading... Show less